The effect of cervical trigger point management on tension type headache

The effect of cervical trigger point management by Positional Release Therapy on the central sensitization in patients with tension type headache

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016071726674N2

Enrollment

Registered

2016-08-23

Start date

2016-07-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tension type headache. Tension-type headache

Interventions

Intervention 1: Control group: Routine treatment. Intervention 2: Intervention group: Positional release Technique.

Treatment - Drugs

Treatment - Other

Control group: Routine treatment

Intervention group: Positional release Technique

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Existence more than 3 months of headache; Existence of any trigger points in cervical muscles. exclusion criteria: other types of headaches; cervical disk herniation; neurological disorders; rheumatoid disorders; history of whiplash injury or head trauma; useage of anti-depressant and anti-anxiety drugs; complain from knee or leg pain.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pressure pain threshold. Timepoint: 5 weeks. Method of measurement: Algometer instrument.;Consentration of Total Choline (tCho). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Concentration of N-Acetyl-Aspartate (NAA). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Consentration of Creatin (Cr). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Concentration of Myo-Inositol (MI). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Concentration of Glx. Timepoint: 5 weeks. Method of measurement: MRS instrument.	—

Measure

Time frame

Pressure pain threshold. Timepoint: 5 weeks. Method of measurement: Algometer instrument.;Consentration of Total Choline (tCho). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Concentration of N-Acetyl-Aspartate (NAA). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Consentration of Creatin (Cr). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Concentration of Myo-Inositol (MI). Timepoint: 5 weeks. Method of measurement: MRS instrument.;Concentration of Glx. Timepoint: 5 weeks. Method of measurement: MRS instrument.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Mohamadi

School of Rehabilitation Sciences, Shiraz University of Medical Sciences

mohamadm@sums.ac.ir+98 71 3627 1551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026